FULGENT THERAPEUTICS, LLC.
NPI: 1518585108
· EL MONTE, CA 91731
· Clinical Medical Laboratory
· NPI assigned 07/09/2020
Billing Flags
· Automated signals — not evidence of fraud
Entity Proliferation
Authorized official KIM, PAUL controls 11+ related entities in our dataset. Read more
$1.56M
Total Medicaid Paid
Provider Details
| Authorized Official | KIM, PAUL (CFO) |
| Parent Organization | FULGENT GENETICS, INC |
| NPI Enumeration Date | 07/09/2020 |
Related Entities
Other providers sharing the same authorized official: KIM, PAUL
Monthly Spending Trend
Yearly Breakdown
| Year | Claims | Total Paid |
|---|
| 2021 |
1,346 |
$28K |
| 2022 |
52,008 |
$1.54M |
Billing Codes
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
24,739 |
21,547 |
$1.17M |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
16,360 |
14,174 |
$214K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
12,230 |
10,943 |
$177K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
25 |
24 |
$2K |